LIDOCAINE HCL AND MENTHOL

LIDOCAINE HCL AND MENTHOL was reported 154 times

LIDOCAINE HCL AND MENTHOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADMINISTRATION SITE NERVE DAMAGE 1 0.1111
1 VENOUS HYPERTENSION 1 0.0556
2 INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION 1 0.0208
3 SECOND DEGREE CHEMICAL BURN OF SKIN 1 0.0167
4 IMMATURE GRANULOCYTE PERCENTAGE INCREASED 1 0.0164
5 OESOPHAGEAL NEOPLASM 1 0.0054
6 BURN INFECTION 1 0.0049
7 MUSCLE HYPERTROPHY 1 0.0028
8 POST-ACUTE COVID-19 SYNDROME 3 0.0024
9 TRANSFERRIN SATURATION DECREASED 1 0.0023
10 WOUND NECROSIS 1 0.0021
11 TYPE V HYPERLIPIDAEMIA 1 0.0021
12 BURNS THIRD DEGREE 2 0.0019
13 HYPERCHLORAEMIA 1 0.0016
14 CHONDROCALCINOSIS 1 0.0015
15 STASIS DERMATITIS 1 0.0015
16 MICROALBUMINURIA 1 0.0013
17 VITAMIN B12 INCREASED 1 0.0013
18 CHEMICAL INJURY 1 0.0012
19 MUSCLE NECROSIS 1 0.0011
20 CHEMICAL BURN 1 0.0009
21 BODY MASS INDEX INCREASED 1 0.0007
22 CARBON DIOXIDE INCREASED 1 0.0007
23 COAGULATION TIME PROLONGED 1 0.0006
24 APPLICATION SITE BURN 3 0.0006
25 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
26 BURNS SECOND DEGREE 1 0.0006
27 ESSENTIAL HYPERTENSION 1 0.0005
28 GRANULOCYTE COUNT DECREASED 1 0.0005
29 STENOSIS 1 0.0005
30 DIABETIC NEPHROPATHY 1 0.0005
31 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
32 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
33 ENERGY INCREASED 2 0.0003
34 NO ADVERSE EVENT 60 0.0003
35 BLOOD CREATININE DECREASED 1 0.0003
36 LYMPHOCYTE COUNT INCREASED 1 0.0003
37 SKIN INJURY 1 0.0003
38 HEPATIC CYST 1 0.0003
39 DIABETIC RETINOPATHY 1 0.0003
40 MONOCYTE COUNT INCREASED 1 0.0003
41 PROTEIN TOTAL DECREASED 1 0.0003
42 HYPERPHAGIA 1 0.0003
43 PERIPHERAL VENOUS DISEASE 1 0.0002
44 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
45 APPLICATION SITE PAIN 5 0.0002
46 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
47 HYPERNATRAEMIA 1 0.0002
48 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
49 PERIPHERAL VASCULAR DISORDER 1 0.0002
50 COMPRESSION FRACTURE 1 0.0002
51 CATARACT OPERATION 1 0.0002
52 APPLICATION SITE VESICLES 1 0.0002
53 WALKING AID USER 1 0.0002
54 PRODUCT FORMULATION ISSUE 1 0.0002
55 APPLICATION SITE RASH 2 0.0001
56 LYMPHOEDEMA 1 0.0001
57 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
58 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
59 NICOTINE DEPENDENCE 1 0.0001
60 MULTIPLE ALLERGIES 1 0.0001
61 FURUNCLE 1 0.0001
62 SCAR 2 0.0001
63 MUSCLE STRAIN 1 0.0001
64 BODY TEMPERATURE DECREASED 1 0.0001
65 LIGAMENT SPRAIN 1 0.0001
66 THERAPEUTIC RESPONSE DECREASED 6 0.0001
67 WOUND INFECTION 1 0.0001
68 NERVE INJURY 1 0.0001
69 MACULAR DEGENERATION 1 0.0001
70 NOCTURIA 1 0.0001
71 NEURALGIA 2 0.0001
72 APPLICATION SITE IRRITATION 1 0.0001
73 INTRAOCULAR PRESSURE INCREASED 1 0.0001
74 PERIPHERAL COLDNESS 1 0.0001
75 BLISTER 4 0.0001
76 SKIN BURNING SENSATION 5 0.0001
77 HYPOKINESIA 1 0.0001
78 OSTEOPENIA 1 0.0001
79 DRUG INEFFECTIVE 85 0.0001
80 CANDIDA INFECTION 1 0.0001
81 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
82 PRODUCT ADHESION ISSUE 2 0.0001
83 PELVIC PAIN 1 0.0001
84 BLOOD URINE PRESENT 1 0.0001
85 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
86 HAEMATOCRIT DECREASED 1 0.0001
87 PRODUCT ADMINISTRATION ERROR 1 0.0000
88 BLINDNESS 2 0.0000
89 DERMATITIS 1 0.0000
90 PRODUCT DISPENSING ERROR 1 0.0000
91 RASH PAPULAR 1 0.0000
92 RASH ERYTHEMATOUS 2 0.0000
93 FIBROMYALGIA 1 0.0000
94 SKIN ULCER 1 0.0000
95 LIMB INJURY 1 0.0000
96 PRODUCT QUALITY ISSUE 5 0.0000
97 SKIN LESION 1 0.0000
98 RESPIRATORY DISORDER 1 0.0000
99 DISCOMFORT 2 0.0000
100 LIMB DISCOMFORT 1 0.0000
101 EYE DISORDER 1 0.0000
102 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
103 EXPIRED PRODUCT ADMINISTERED 1 0.0000
104 TYPE 2 DIABETES MELLITUS 1 0.0000
105 HEART RATE DECREASED 1 0.0000
106 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
107 PSORIATIC ARTHROPATHY 1 0.0000
108 NEUTROPHIL COUNT DECREASED 1 0.0000
109 OSTEOPOROSIS 1 0.0000
110 OSTEOARTHRITIS 1 0.0000
111 HYPOACUSIS 1 0.0000
112 MUSCULOSKELETAL STIFFNESS 2 0.0000
113 LIVER DISORDER 1 0.0000
114 TACHYCARDIA 2 0.0000
115 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
116 NEPHROLITHIASIS 1 0.0000
117 NEUROPATHY PERIPHERAL 2 0.0000
118 ATRIAL FIBRILLATION 2 0.0000
119 DRY EYE 1 0.0000
120 LEUKOPENIA 1 0.0000
121 CELLULITIS 1 0.0000
122 INFLAMMATION 1 0.0000
123 ECZEMA 1 0.0000
124 DEPRESSED MOOD 1 0.0000
125 RASH PRURITIC 1 0.0000
126 ANAPHYLACTIC REACTION 1 0.0000
127 ARTHROPATHY 1 0.0000
128 OXYGEN SATURATION DECREASED 1 0.0000
129 HYPONATRAEMIA 1 0.0000
130 HERPES ZOSTER 1 0.0000
131 EYE IRRITATION 1 0.0000
132 WHEEZING 1 0.0000
133 PRODUCT USE ISSUE 3 0.0000
134 BLOOD PRESSURE DECREASED 1 0.0000
135 BURNING SENSATION 1 0.0000
136 THERAPY INTERRUPTED 1 0.0000
137 MOBILITY DECREASED 1 0.0000
138 RASH 6 0.0000
139 PAIN IN EXTREMITY 4 0.0000
140 BRONCHITIS 1 0.0000
141 HOT FLUSH 1 0.0000
142 ARTHRITIS 1 0.0000
143 FEELING ABNORMAL 3 0.0000
144 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
145 URTICARIA 2 0.0000
146 SKIN EXFOLIATION 1 0.0000
147 PRODUCT STORAGE ERROR 1 0.0000
148 INTENTIONAL PRODUCT MISUSE 1 0.0000
149 PRODUCT DOSE OMISSION ISSUE 3 0.0000
150 CONDITION AGGRAVATED 3 0.0000
151 PAIN 6 0.0000
152 CHEST DISCOMFORT 1 0.0000
153 HAEMORRHAGE 1 0.0000
154 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
155 FALL 3 0.0000
156 SEPSIS 1 0.0000
157 WEIGHT INCREASED 2 0.0000
158 SEIZURE 1 0.0000
159 PALPITATIONS 1 0.0000
160 VISUAL IMPAIRMENT 1 0.0000
161 PRURITUS 3 0.0000
162 LOSS OF CONSCIOUSNESS 1 0.0000
163 HYPERHIDROSIS 1 0.0000
164 INSOMNIA 2 0.0000
165 MEMORY IMPAIRMENT 1 0.0000
166 COUGH 2 0.0000
167 ANXIETY 2 0.0000
168 HYPOAESTHESIA 1 0.0000
169 HOSPITALISATION 1 0.0000
170 PERIPHERAL SWELLING 1 0.0000
171 PARAESTHESIA 1 0.0000
172 DIZZINESS 3 0.0000
173 ABDOMINAL DISCOMFORT 1 0.0000
174 URINARY TRACT INFECTION 1 0.0000
175 COVID-19 1 0.0000
176 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
177 BLOOD GLUCOSE INCREASED 1 0.0000
178 GAIT DISTURBANCE 1 0.0000
179 SOMNOLENCE 1 0.0000
180 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
181 ERYTHEMA 1 0.0000
182 HYPERTENSION 1 0.0000
183 CONSTIPATION 1 0.0000
184 MALAISE 2 0.0000
185 DECREASED APPETITE 1 0.0000
186 BACK PAIN 1 0.0000
187 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
188 FATIGUE 3 0.0000
189 PNEUMONIA 1 0.0000
190 ARTHRALGIA 1 0.0000
191 OFF LABEL USE 2 0.0000
192 DYSPNOEA 1 0.0000
193 HEADACHE 1 0.0000
194 DIARRHOEA 1 0.0000
195 DEATH 1 0.0000